Mercaptopurine

Welcome to Dwaey, specifically on Mercaptopurine page.
This medicine contains important and useful components, as it consists of
Mercaptopurine is available in the market in concentration.

Generic Name of Mercaptopurine - Learn More

Mercaptopurine

Mercaptopurine Precaution - What You Need to Know

Mercaptopurine is an immunosuppressive medication that must be used with caution due to its potential for significant side effects, especially related to bone marrow suppression. Patients using mercaptopurine should be regularly monitored for blood cell counts, as the drug can cause leukopenia, thrombocytopenia, and anemia. Pregnant women should avoid using mercaptopurine unless absolutely necessary, as it can be teratogenic and cause birth defects or miscarriage. This medication also crosses into breast milk, so breastfeeding should be avoided. Additionally, mercaptopurine can affect liver function, so liver enzymes should be regularly checked, especially during the initial phases of treatment. Patients with pre-existing liver disease or a history of jaundice should be monitored closely. People with a deficiency in thiopurine methyltransferase (TPMT) may have a higher risk of toxicity due to altered drug metabolism, so genetic testing is recommended before initiating therapy. As mercaptopurine can suppress the immune system, patients should be advised to avoid exposure to infections, including live vaccines.

Mercaptopurine Indication - Uses and Benefits

Mercaptopurine is primarily indicated for the treatment of certain types of cancer, including acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and other hematologic malignancies. It is also commonly used to treat autoimmune conditions like Crohn’s disease and ulcerative colitis, where it works as an immunosuppressive agent to reduce inflammation and prevent flare-ups. By inhibiting purine metabolism, mercaptopurine interferes with DNA and RNA synthesis, which in turn reduces the proliferation of rapidly dividing cells, such as cancerous or autoimmune cells. While its use in cancer is well-established, mercaptopurine is also used off-label in other conditions, including organ transplant rejection prevention, though this is not as common. The decision to use mercaptopurine for any condition should be made under the guidance of a healthcare provider, with careful monitoring for side effects and efficacy.

Mercaptopurine Contraindications - Important Warnings

Mercaptopurine is contraindicated in patients who have a known hypersensitivity to mercaptopurine or any of its components. It should also not be used in patients with severe liver impairment or those with a history of jaundice or hepatitis due to its potential hepatotoxicity. Additionally, mercaptopurine is contraindicated in individuals with a genetic deficiency in thiopurine methyltransferase (TPMT), an enzyme essential for its metabolism. These patients may be at greater risk for severe bone marrow suppression. The medication is also contraindicated in pregnant women unless the potential benefits outweigh the risks, as it can cause birth defects, fetal harm, or miscarriage. Mercaptopurine should not be used during active infections, as it suppresses the immune system and may exacerbate the infection. Live vaccines are also contraindicated during treatment because of the immunosuppressive effects of mercaptopurine.

Mercaptopurine Side Effects - What to Expect

Common side effects of mercaptopurine include bone marrow suppression, which can lead to anemia, leukopenia, and thrombocytopenia, increasing the risk of infection and bleeding. Other frequent side effects include nausea, vomiting, and loss of appetite. Patients may also experience hepatotoxicity, indicated by elevated liver enzymes, jaundice, or abdominal discomfort. Long-term use of mercaptopurine can increase the risk of certain cancers, including lymphomas. Other potential adverse effects include gastrointestinal disturbances, mouth ulcers, hair loss, and skin rash. In rare cases, mercaptopurine can lead to severe infections due to its immunosuppressive effects, or pancreatitis, which can present as severe abdominal pain, vomiting, and elevated pancreatic enzymes. If any signs of these serious side effects occur, the patient should seek medical attention immediately. Regular blood tests and liver function monitoring are recommended to detect early signs of bone marrow suppression or liver damage.

Mercaptopurine Pregnancy Category ID - Safety Information

4

Mercaptopurine Mode of Action - How It Works

Mercaptopurine works by interfering with purine metabolism, which is essential for DNA and RNA synthesis. It is a prodrug that is converted in the body to its active form, 6-thioguanine nucleotides, which are incorporated into DNA and RNA. This incorporation disrupts the normal function of these molecules, inhibiting the replication of cells, particularly those that divide rapidly, such as cancerous cells in leukemia or autoimmune cells in inflammatory diseases like Crohn's disease and ulcerative colitis. The drug specifically targets purine metabolism by inhibiting enzymes involved in purine biosynthesis, thereby reducing the ability of cells to proliferate. This makes mercaptopurine effective in controlling rapidly proliferating cancer cells or immune cells in autoimmune conditions, although the drug’s ability to suppress normal, healthy cells also contributes to its side effect profile.

Mercaptopurine Drug Interactions - What to Avoid

Mercaptopurine has several important drug-drug interactions. Its metabolism is heavily influenced by TPMT activity, and medications that inhibit TPMT (such as allopurinol) can increase mercaptopurine’s toxicity, leading to severe bone marrow suppression. Concomitant use of mercaptopurine and allopurinol should be approached cautiously, and dose reductions of mercaptopurine may be necessary. Additionally, mercaptopurine can interact with other immunosuppressive medications, such as corticosteroids or other chemotherapy agents, potentially increasing the risk of infections or other side effects. Antibiotics, especially those that affect gut flora, can also influence mercaptopurine’s effectiveness, as they may alter the drug’s absorption. Patients should avoid using live vaccines while on mercaptopurine, as the drug impairs immune function, which could lead to the development of vaccine-associated diseases. Close monitoring is essential when mercaptopurine is used in combination with other drugs that affect the liver or bone marrow.

Mercaptopurine Adult Dose - Recommended Dosage

The standard adult dose of mercaptopurine depends on the condition being treated. For acute lymphoblastic leukemia (ALL), the typical starting dose is 1.5–2.5 mg/kg/day, administered orally. For maintenance therapy in ALL, doses may be adjusted based on the patient’s response and tolerability. In autoimmune conditions such as Crohn’s disease or ulcerative colitis, the dose usually ranges from 1–1.5 mg/kg/day. The dosage may be adjusted depending on the patient's response and the results of blood tests, particularly liver enzymes and complete blood counts. The dose of mercaptopurine is often reduced in patients with reduced TPMT activity or those taking drugs that affect its metabolism, such as allopurinol. Treatment should be closely monitored by a healthcare provider, with regular blood tests to assess for toxicity, especially during the initiation phase.

Mercaptopurine Child Dose - Dosage for Children

In children, mercaptopurine is often used for the treatment of acute lymphoblastic leukemia (ALL) and certain autoimmune conditions. The typical starting dose is 1.5–2.5 mg/kg/day, administered orally. The dose may be adjusted based on the child’s response, laboratory results, and clinical status. Regular monitoring of blood counts and liver function is essential, as children are more susceptible to the bone marrow-suppressive effects of the drug. In the case of TPMT deficiency, mercaptopurine should be administered with caution, and the dose may need to be significantly reduced. Pediatric patients receiving mercaptopurine should be closely monitored by a healthcare provider to detect any signs of adverse effects early.

Mercaptopurine Renal Dose - Dosage for Kidney Conditions

Renal function does not significantly affect the pharmacokinetics of mercaptopurine; however, patients with renal impairment should still use the drug cautiously. The active metabolites of mercaptopurine are cleared through the liver, so no direct renal dose adjustments are typically required. However, if the patient has severe renal impairment, particularly in the context of other comorbidities, close monitoring for adverse effects like bone marrow suppression is essential. Renal dysfunction can potentially exacerbate the drug's toxicity due to altered metabolism or elimination, so caution is recommended, especially in cases of acute renal failure or dialysis.